Poseida Therapeutics Named to Newsweeks List of the Top 200 Americas Most Loved Workplaces for 2024
Slightly above 67% of Poseida Therapeutics' investor base is looking to short. The analysis of current outlook of investing in Poseida Therapeutics suggests that many traders are alarmed regarding Poseida Therapeutics' prospects. Poseida Therapeutics' investing sentiment can be driven by a variety of factors including economic data, Poseida Therapeutics' earnings reports, geopolitical events, and overall market trends.
Poseida |
Poseida Therapeutics, Inc. , a clinical-stage allogeneic cell therapy and genetic medicines company advancing differentiated non-viral treatments for patients with cancer and rare diseases, today announced its inclusion in Newsweek Magazines annual Americas Top Most Loved Workplaces list, developed by Most Loved Workplace, a division of Best Practice Institute .
Read at finance.yahoo.com
 |
Poseida Therapeutics Fundamental Analysis
We analyze Poseida Therapeutics' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Poseida Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Poseida Therapeutics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Current Asset
Current Asset Comparative Analysis
Poseida Therapeutics is currently under evaluation in current asset category among its peers. Current Asset is all of the company's assets that can be used to pay off current liabilities within the current fiscal period or over the next 12 months. Current Asset includes cash or cash equivalents, accounts receivable, short-term investments, and the portion of prepaid liabilities which will be paid within the next 12 months. Because these assets are easily turned into cash, they are sometimes referred to as liquid assets.
Poseida Therapeutics Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Poseida Therapeutics stock to make a market-neutral strategy. Peer analysis of Poseida Therapeutics could also be used in its relative valuation, which is a method of valuing Poseida Therapeutics by comparing valuation metrics with similar companies.
Peers
Poseida Therapeutics Related Equities
| MOLN | Molecular Partners | 4.70 | ||||
| LTRN | Lantern Pharma | 3.78 | ||||
| MLYS | Mineralys Therapeutics, | 3.68 | ||||
| DYN | Dyne Therapeutics | 3.24 | ||||
| PASG | Passage Bio | 1.87 | ||||
| CYTK | Cytokinetics | 1.59 | ||||
| IPSC | Century Therapeutics | 0.80 | ||||
| CUE | Cue Biopharma | 0.80 | ||||
| PLRX | Pliant Therapeutics | 0.32 | ||||
| ANTX | AN2 Therapeutics | 0.88 | ||||
| RVMD | Revolution Medicines | 1.40 | ||||
| PHVS | Pharvaris | 2.15 | ||||
| RVPH | Reviva Pharmaceuticals | 2.84 | ||||
| STOK | Stoke Therapeutics | 3.41 | ||||
| GBIO | Generation Bio | 3.55 | ||||
| INAB | In8bio | 3.70 | ||||
| PEPG | PepGen | 6.43 |
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.
Other Consideration for investing in Poseida Stock
If you are still planning to invest in Poseida Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Poseida Therapeutics' history and understand the potential risks before investing.
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments |